U
QSAM Biosciences, Inc. A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income 58.85% 5.63% 3.55% 15.73% 67.45%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -100.00% -100.00% -100.00% 298.90% --
Total Other Non-Cash Items -88.62% -15.11% -14.15% 43.24% -82.30%
Change in Net Operating Assets -57.12% 8.28% -83.57% -61.87% -280.17%
Cash from Operations -0.76% 2.64% -81.70% 33.54% -79.84%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -79.06% -45.95% -- -- 2.05%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 339.79% -45.95% -- 2,947.43% -55.49%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 239.44% -87.89% -4.29% 199.73% -255.80%
Weiss Ratings